title: Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.
abstract: An Italian Olympic athlete with a severe form of Behçet's disease was given infliximab. He had oral aphthosis, papulopustular and follicular lesions, and a bilateral cystoid macular edema. After the first 3 infusions, the mucocutaneous lesions disappeared and cystoid macular edema was much improved. Cyclosporine was stopped and the prednisone dose was progressively tapered until the cystoid macular edema disappeared.
authors.affiliation: Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy. ignazioolivieri@tiscalinet.it
authors.forename: Ignazio
authors.initials: I
authors.lastname: Olivieri
authors.forename: Loredana
authors.initials: L
authors.lastname: Latanza
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Siringo
authors.forename: Giovanni
authors.initials: G
authors.lastname: Peruz
authors.forename: Valentina
authors.initials: V
authors.lastname: Di Iorio
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D012074:Remission Induction / Q000379:methods; D013177:Sports; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab